Skip to content
Monday, March 20, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Pharmacosmos expands global reach with launch of Monofer in Japanese market
  • Saudi retail pharmacy chain Nahdi posts US$236 million net profit in Q4
  • Saudi healthtech startup Aumet snaps up US$7M in a pre-Series A funding round
  • Cosmos Health expands telehealth services with acquisition of ZipDoctor
  • Pear Therapeutics considers sale and other options to maximize shareholder value
  • UAE-based medical school MBRU earns top-level institutional accreditation
  • Pfizer recalls over 4 million packages of prescription migraine medicine voluntarily
  • Enzo Biochem agrees to sell clinical laboratory services business to LabCorp
  • Samsung Biologics invests in capacity expansion with fifth plant
  • Gulf Medical University marks World Sleep Day with an array of activities
You are here
  • Home
  • Regeneron

Tag: Regeneron

Sanofi’s Dupixent wins US approval for expanded use

23 May 202223 May 2022

USA – Sanofi and Regeneron have added another string to the bow of their immunology blockbuster Dupixent with an FDA approval for treatment of oesophagitis (EoE), which could help the…

Read More

Regeneron beefs up oncotherapy portfolio with US$250M Checkmate Pharma buyout

20 April 202220 April 2022

USA – Regeneron Pharmaceuticals has shelled out US$250 million cash to acquire Checkmate Pharmaceuticals, a clinical-stage biotech developing drugs that activate the innate immune system. Regeneron will pay US$10.50 in…

Read More

FDA approves Sanofi’s Enjaymo for treatment of rare blood disease

7 February 20227 February 2022

FRANCE – The US FDA has approved Enjaymo (sutimlimab-jome) infusion to reduce the need for red blood cell transfusion due to hemolysis (red blood cell destruction) in adults with cold…

Read More

Pfizer backs out of vupanorsen development, hands back rights to partner Ionis

1 February 20221 February 2022

USA – Pfizer has terminated its collaboration with Ionis for the cholesterol-lowering therapy vupanorsen, following a review of phase 2b data that raised concerns about the antisense drug’s efficacy and…

Read More

Roche looks to compete against Regeneron’s blockbuster with its newly approved vision drug

31 January 202231 January 2022

SWITZERLAND – Roche announced that it has received FDA approval for the first-ever bispecific antibody treatment for two common causes of vision loss, paving the way for a battle with…

Read More

Roche’s arthritis drug scores EMA approval for treating severe Covid-19

7 December 20217 December 2021

NETHERLANDS – The European Medicines Agency (EMA) has recommended extending the use of Roche’s RoActemra arthritis drug for adult COVID-19 patients receiving systemic steroid treatment and those requiring oxygen support…

Read More

GSK & Vir Biotech sign pact with U.S to supply Covid-19 antibody therapy doses worth US$1 billion

23 November 202123 November 2021

USA – The US government has signed contracts worth approximately US$1 billion to secure the antibody-based Covid-19 treatment developed by GlaxoSmithKline (GSK) and Vir Biotechnology, the drug makers have announced.…

Read More

Denmark’s Novo Nordisk reaches US$3.3 billion deal to acquire Dicerna Pharma

19 November 202119 November 2021

DENMARK – Novo Nordisk, a Danish pharmaceutical company, has agreed to buy Dicerna Pharmaceuticals for US$3.3 billion in cash, the company has announced. Dicerna Pharmaceuticals creates RNAi-based therapies that selectively…

Read More

Roche terminates partnership to develop COVID-19 pill with Atea

17 November 202117 November 2021

SWITZERLAND – Roche Holding AG has terminated its collaboration with Atea Pharmaceuticals Inc.to develop a COVID-19 antiviral pill, the Swiss drugmaker has announced. The partnership termination has happened a month…

Read More

Pfizer’s new antiviral pill cuts hospitalization risk, death from Covid-19 by nearly 90%

7 November 202122 September 2022

USA – Pfizer has announced that Paxlovid, an investigational oral antiviral, reduced COVID-19-related hospitalizations and deaths by 89 percent in a phase 2/3 study of nonhospitalized adults at high risk…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • Pharmacosmos expands global reach with launch of Monofer in Japanese market
  • Saudi retail pharmacy chain Nahdi posts US$236 million net profit in Q4
  • Saudi healthtech startup Aumet snaps up US$7M in a pre-Series A funding round
  • Cosmos Health expands telehealth services with acquisition of ZipDoctor
  • Pear Therapeutics considers sale and other options to maximize shareholder value

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

LATEST TWEETS

HealthCare Middle East & Africa Follow

No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa, Middle East & the World

HealthCareAfro
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Gulf Pharmaceutical Industries @JulpharUAE has appointed Mr. Basel Ziyadeh as the new Chief Executive Officer of its manufacturing business

https://t.co/8AFhARFMmO

#appointments #healthcare #leadership #middleeast #UAE #pharmaceuticals #pharma #manufacturing #Sustainability

Reply on Twitter 1626130056736276482 Retweet on Twitter 1626130056736276482 Like on Twitter 1626130056736276482 1 Twitter 1626130056736276482
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Santechture has secured an undisclosed amount of funding from Gulf Capital (GC) and @ShorooqPartners to further develop its platform, expand its services, and grow its team

https://t.co/pffgXv4Dii

#Funding #Health #technologies #UAE #SaudiArabia #MiddleEast #DiGiTALhealth

Reply on Twitter 1626127995068104707 Retweet on Twitter 1626127995068104707 1 Like on Twitter 1626127995068104707 1 Twitter 1626127995068104707
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Moroccan drug maker Laprophan has entered into an exclusive cooperation agreement with @SinopharmIntl for the production of medicines

https://t.co/XqJU3BADf3

#healthcare #manufacturing #pharmaceuticals #medicines #Africa #partnerships #Health #Morocco #China #PublicHealth

Reply on Twitter 1626125115074449408 Retweet on Twitter 1626125115074449408 Like on Twitter 1626125115074449408 Twitter 1626125115074449408
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Discovery Health launches new affordable private healthcare in partnership with Clicks and Auto & General

https://t.co/J1fPrRSf2X

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory

Reply on Twitter 1626103265409781761 Retweet on Twitter 1626103265409781761 Like on Twitter 1626103265409781761 3 Twitter 1626103265409781761
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

President William Ruto officially commissions the @AarHospital

https://t.co/Z7bGiyAUHe

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory #health #medical #hospital

Reply on Twitter 1626102988266962945 Retweet on Twitter 1626102988266962945 2 Like on Twitter 1626102988266962945 2 Twitter 1626102988266962945
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.